Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Clinical Training Award Cycle 3 2017
Middleton, Gary
(Principal Investigator)
Immunology and Immunotherapy
Overview
Fingerprint
Research output
(1)
Project Details
Short title
Clinical Training Award Cycle 3 2017
Status
Finished
Effective start/end date
1/09/17
→
31/12/22
Funding
Cancer Research Uk
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Myeloid-Derived Suppressor Cells
Medicine & Life Sciences
100%
Colorectal Neoplasms
Medicine & Life Sciences
59%
Phenotype
Medicine & Life Sciences
45%
HLA-DR Antigens
Medicine & Life Sciences
36%
Monocytes
Medicine & Life Sciences
27%
T-Lymphocytes
Medicine & Life Sciences
25%
Conditioned Culture Medium
Medicine & Life Sciences
17%
Cell Proliferation
Medicine & Life Sciences
16%
Research output
Research output per year
2021
2021
2021
1
Article
Research output per year
Research output per year
TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer
Gneo, L.
,
Rizkalla, N.
,
Hejmadi, R.
,
Mussai, F.
,
de Santo, C.
&
Middleton, G.
,
2 Nov 2021
,
In:
Cancer Immunology Immunotherapy.
14 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Myeloid-Derived Suppressor Cells
100%
Colorectal Neoplasms
59%
Phenotype
45%
HLA-DR Antigens
36%
Monocytes
27%
88
Downloads (Pure)